Empower Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$149M Buy
353,043
+3,376
+1% +$1.35M 0.35% 51
2026
Q2
$127M Buy
349,667
+7,255
+2% +$2.48M 0.3% 61
2026
Q1
$120M Buy
342,412
+9,341
+3% +$3.33M 0.31% 59
2025
Q4
$109M Buy
333,071
+523
+0.2% +$166K 0.29% 66
2025
Q3
$93.8M Buy
332,548
+8,068
+2% +$2.34M 0.26% 77
2025
Q2
$90.6M Buy
324,480
+9,951
+3% +$2.82M 0.27% 74
2025
Q1
$98M Buy
314,529
+11,063
+4% +$3.27M 0.32% 59
2024
Q4
$79.1M Sell
303,466
-116,879
-28% -$34.7M 0.27% 76
2024
Q3
$135M Buy
420,345
+2,682
+0.6% +$877K 0.46% 41
2024
Q2
$130M Sell
417,663
-505
-0.1% -$148K 0.48% 40
2024
Q1
$119M Sell
418,168
-2,284
-0.5% -$668K 0.45% 46
2023
Q4
$121M Buy
420,452
+3,861
+0.9% +$1.05M 0.48% 40
2023
Q3
$112M Buy
416,591
+6,601
+2% +$1.65M 0.5% 35
2023
Q2
$91M Buy
409,990
+9,065
+2% +$2.1M 0.39% 52
2023
Q1
$98M Buy
400,925
+10,496
+3% +$2.58M 0.44% 42
2022
Q4
$103M Buy
390,429
+1,315
+0.3% +$352K 0.5% 39
2022
Q3
$87.7M Buy
389,114
+8,862
+2% +$2.15M 0.47% 43
2022
Q2
$92.5M Buy
380,252
+7,293
+2% +$1.79M 0.48% 36
2022
Q1
$90.2M Buy
372,959
+29,054
+8% +$6.68M 0.42% 48
2021
Q4
$77.5M Buy
343,905
+31,032
+10% +$6.55M 0.36% 60
2021
Q3
$66.5M Buy
312,873
+4,118
+1% +$948K 0.33% 69
2021
Q2
$75.3M Buy
308,755
+24,346
+9% +$5.99M 0.39% 56
2021
Q1
$70.8M Buy
284,409
+20,889
+8% +$4.98M 0.41% 49
2020
Q4
$60.6M Buy
263,520
+12,438
+5% +$2.87M 0.39% 54
2020
Q3
$63.8M Buy
251,082
+1,346
+0.5% +$333K 0.48% 41
2020
Q2
$58.9M Buy
249,736
+921
+0.4% +$210K 0.49% 39
2020
Q1
$50.6M Buy
248,815
+5,967
+2% +$1.3M 0.5% 39
2019
Q4
$58.5M Buy
242,848
+12,427
+5% +$2.74M 0.49% 38
2019
Q3
$44.6M Buy
230,421
+1,839
+0.8% +$353K 0.43% 55
2019
Q2
$42.1M Buy
228,582
+19,696
+9% +$3.53M 0.43% 55
2019
Q1
$39.7M Buy
208,886
+13,575
+7% +$2.59M 0.45% 55
2018
Q4
$38M Buy
195,311
+8,424
+5% +$1.64M 0.51% 45
2018
Q3
$38.7M Buy
186,887
+9,831
+6% +$1.94M 0.5% 45
2018
Q2
$32.7M Buy
177,056
+17,185
+11% +$3.04M 0.46% 49
2018
Q1
$27.3M Buy
159,871
+28,486
+22% +$5.23M 0.42% 63
2017
Q4
$22.8M Buy
131,385
+15,628
+14% +$2.77M 0.39% 67
2017
Q3
$21.6M Buy
115,757
+14,519
+14% +$2.57M 0.42% 68
2017
Q2
$17.4M Buy
101,238
+37,774
+60% +$6.14M 0.38% 77
2017
Q1
$10.3M Buy
63,464
+38,643
+156% +$6.42M 0.26% 94
2016
Q4
$3.63M Buy
24,821
+1,642
+7% +$247K 0.11% 124
2016
Q3
$3.84M Buy
23,179
+3,889
+20% +$658K 0.13% 113
2016
Q2
$2.94M Buy
19,290
+3,988
+26% +$620K 0.11% 121
2016
Q1
$2.29M Buy
15,302
+3,250
+27% +$483K 0.11% 115
2015
Q4
$1.96M Buy
12,052
+2,432
+25% +$382K 0.11% 111
2015
Q3
$1.33M Buy
9,620
+742
+8% +$117K 0.09% 114
2015
Q2
$1.39M Buy
8,878
+1,814
+26% +$291K 0.1% 105
2015
Q1
$1.13M Buy
7,064
+2,234
+46% +$352K 0.09% 98
2014
Q4
$769K Buy
4,830
+1,670
+53% +$260K 0.08% 102
2014
Q3
$444K Buy
+3,160
New +$413K 0.06% 101

Other funds holding AMGN

Empower Advisory Group's AMGN Position: Q3 2026 in Review

Empower Advisory Group increased its Amgen (AMGN) stake by 0.97% in Q3 2026, buying an estimated $1.35M and bringing the position to 353,043 shares worth $149M. The position accounts for 0.35% of the portfolio, ranked #51.

Empower Advisory Group first reported a position in AMGN in Q3 2014 and has held it in 49 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Empower Advisory Group held 353,043 shares of Amgen worth $149M as of Q3 2026.
  • Empower Advisory Group bought 3,376 Amgen shares in Q3 2026, an estimated $1.35M.
  • Amgen made up 0.35% of Empower Advisory Group's portfolio in Q3 2026, its #51 holding.
  • Empower Advisory Group first reported a position in Amgen in Q3 2014 and has held it in 49 quarters since.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Empower Advisory Group's 13F filing for Q3 2026, filed 13 Nov 2026.